… We observed a clear decrease in TBII levels in patients with a favourable outcome, whereas
TBII levels remained elevated in non-responders. However, a clear relationship between …

… those who received rituximab and low-dose prednisolone and … and relapse rates were
significantly reduced in rituximab-… determine the dose of re-treatment of rituximab in relapses. We …

… rituximab in 13 patients whose B-NHL relapsed after they showed an initial response to
rituximab… Several factors may lead to resistance to rituximab treatment, including a decrease in …

… , leading to reduced relapse rates and an increase in time to relapse 5 . Rituximab has been
given on a prophylactic basis to patients deemed to be at high risk of an acute TTP relapse (…

… the last infusion of rituximab, and the patient experienced a clinical relapse (purpura flares)
… levels and reduced corticosteroid dosage in our two patients. Likewise, rituximab has shown …

… at the 24-week end point with rituximab therapy. Of these 7 … and all achieved successful
dose reduction. For the secondary … to rituximab measured at 24 weeks but experienced relapse …

… of less than 25,000/μL, doses were only reduced by 20%, irrespective of the … dose-adjusted
EPOCH in 50 patients with large B-cell lymphomas, where we observed a 25% rate of relapse…

… Mycophenolate Mofetil Protocol to Reduce Outbreaks of Vasculitides study in which … decrease
in the rate of relapses compared with MMF ( 24 ). The demonstrated efficacy of rituximab in …

… of rituximab, the standard therapeutic approach for relapsed DLBCL was to decrease the …
the remission status with high-dose therapy and autologous stem cell transplantation (ASCT). …

… single-dose rituximab strategy for the treatment of recurrent GN … unique rituximab regimen
for the treatment of recurrent GN … of this work, but the reduced rate of acute rejection and delay …